Abdominal adipose tissue and liver fat imaging in very low birth weight adults born preterm: birth cohort with sibling-controls.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 06 2022
Historique:
received: 28 02 2022
accepted: 30 05 2022
entrez: 14 6 2022
pubmed: 15 6 2022
medline: 18 6 2022
Statut: epublish

Résumé

Preterm birth at very low birth weight (VLBW, < 1500 g) is associated with an accumulation of cardiovascular and metabolic risk factors from childhood at least to middle age. Small-scale studies suggest that this could partly be explained by increased visceral or ectopic fat. We performed magnetic resonance imaging on 78 adults born preterm at VLBW in Finland between 1978 and 1990 and 72 term same-sex siblings as controls, with a mean age of 29 years. We collected T1-weighted images from the abdomen, and magnetic resonance spectra from the liver, subcutaneous abdominal adipose tissue, and tibia. The adipose tissue volumes of VLBW adults did not differ from their term siblings when adjusting for age, sex, and maternal and perinatal factors. The mean differences were as follows: subcutaneous - 0.48% (95% CI - 14.8%, 16.3%), visceral 7.96% (95% CI - 10.4%, 30.1%), and total abdominal fat quantity 1.05% (95% CI - 13.7%, 18.4%). Hepatic triglyceride content was also similar. VLBW individuals displayed less unsaturation in subcutaneous adipose tissue (- 4.74%, 95% CI - 9.2%, - 0.1%) but not in tibial bone marrow (1.68%, 95% CI - 1.86%, 5.35%). VLBW adults displayed similar adipose tissue volumes and hepatic triglyceride content as their term siblings. Previously reported differences could thus partly be due to genetic or environmental characteristics shared between siblings. The VLBW group displayed less unsaturation in subcutaneous abdominal adipose tissue, suggesting differences in its metabolic activity and energy storage.

Identifiants

pubmed: 35701494
doi: 10.1038/s41598-022-13936-1
pii: 10.1038/s41598-022-13936-1
pmc: PMC9198082
doi:

Substances chimiques

Triglycerides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9905

Informations de copyright

© 2022. The Author(s).

Références

Hypertension. 2020 Dec;76(6):1838-1846
pubmed: 33100047
Child Obes. 2020 Dec;16(8):549-553
pubmed: 33064560
PLoS One. 2017 Mar 9;12(3):e0173349
pubmed: 28278233
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
Eur J Pediatr. 2020 May;179(5):757-771
pubmed: 31901983
Early Hum Dev. 2012 Mar;88 Suppl 1:S19-24
pubmed: 22261288
Horm Metab Res. 2002 Feb;34(2):72-6
pubmed: 11972290
Int J Obes (Lond). 2013 Apr;37(4):620-2
pubmed: 22641063
Pediatrics. 2003 Jul;112(1 Pt 1):e30-8
pubmed: 12837903
Sci Rep. 2016 Aug 17;6:31560
pubmed: 27530702
PLoS Med. 2019 Oct 18;16(10):e1002947
pubmed: 31626652
BMC Public Health. 2021 Feb 9;21(1):321
pubmed: 33563247
J Clin Endocrinol Metab. 2008 Oct;93(10):3804-9
pubmed: 18628518
Int J Obes (Lond). 2007 Sep;31(9):1392-9
pubmed: 17356523
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4437-4446
pubmed: 30099519
Lancet. 2012 Jun 9;379(9832):2162-72
pubmed: 22682464
PLoS One. 2011 Mar 25;6(3):e17700
pubmed: 21464981
J Clin Endocrinol Metab. 2006 Jun;91(6):2153-8
pubmed: 16537681
Obes Rev. 2010 Jan;11(1):11-8
pubmed: 19656312
Am J Epidemiol. 2015 Jun 1;181(11):861-73
pubmed: 25947956
N Engl J Med. 2007 May 17;356(20):2053-63
pubmed: 17507704
PLoS One. 2012;7(2):e32430
pubmed: 22384247
J Pediatr. 2019 Jul;210:69-80.e5
pubmed: 30992219
Pediatrics. 2016 Oct;138(4):
pubmed: 27590899
Chronobiol Int. 2020 Jul;37(7):1023-1033
pubmed: 32354238
NMR Biomed. 2010 Jun;23(5):466-72
pubmed: 20099371
Metabolism. 2016 Sep;65(9):1230-7
pubmed: 27506730
Metabolism. 2015 Nov;64(11):1574-81
pubmed: 26388537
Obes Res. 2003 Jan;11(1):5-16
pubmed: 12529479
Hypertension. 2016 Oct;68(4):880-7
pubmed: 27572149
J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):153-6
pubmed: 25153564
Pediatr Res. 2011 Nov;70(5):507-12
pubmed: 21772225
J Dev Orig Health Dis. 2016 Aug;7(4):369-73
pubmed: 27256709
Eur J Epidemiol. 2013 Jan;28(1):87-98
pubmed: 23354981
J Pediatr. 2017 Aug;187:141-146.e1
pubmed: 28366357

Auteurs

Juho Kuula (J)

Department of Radiology, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. juho.kuula@helsinki.fi.
Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland. juho.kuula@helsinki.fi.

Jesper Lundbom (J)

Department of Radiology, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Antti Hakkarainen (A)

Department of Radiology, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Petteri Hovi (P)

Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.

Helena Hauta-Alus (H)

Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.
Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism (CAMM), Faculty of Medicine, University of Helsinki, Helsinki, Finland.
PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.

Nina Kaseva (N)

Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.

Samuel Sandboge (S)

Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.
Psychology/Welfare Sciences, Faculty of Social Sciences, University of Tampere, Tampere, Finland.

Johan Björkqvist (J)

Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.

Johan Eriksson (J)

Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland.
Folkhälsan Research Center, Helsinki, Finland.
Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Human Potential Translational Research Programme and Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Kirsi H Pietiläinen (KH)

Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Obesity Center, Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Nina Lundbom (N)

Department of Radiology, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Eero Kajantie (E)

Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.
PEDEGO Research Unit, MRC Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Children's Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH